Problems In Determining Her2 Status In Breast Carcinoma
Objective:Human epidermal growth factor receptor 2 (HER2) oncoprotein is overexpressed in 15-25% of breast carcinomas and associated with poor outcome. Assessment of HER2 status accurately is important to select patients who will benefit from targeted therapy.Materials and Methods:In this study immu...
Main Authors: | Emel Ebru Pala, Ümit Bayol, Alp Özgüzer, Ülkü Küçük, Çağlar Yıldız Akdeniz, Özlem Sezer |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Publishing House
2015-01-01
|
Series: | European Journal of Breast Health |
Subjects: | |
Online Access: |
http://www.eurjbreasthealth.com/archives/archive-detail/article-preview/problems-n-determining-her2-status-n-breast-carcin/42210
|
Similar Items
-
<i>ERBB2</i> Amplification as a Predictive and Prognostic Biomarker in Upper Tract Urothelial Carcinoma
by: Annette Zimpfer, et al.
Published: (2023-04-01) -
Fluorescence in situ hybridization (FISH) : application guide /
by: Liehr, Thomas
Published: (2009) -
FISH technology /
by: Rautenstrauss, Bernd W., 1959-, et al.
Published: (2002) -
Amplification of HER-2 Gene in Benign and Malignant Breast Lesions in a Sample of Iraqi Women
by: Maysoon Abdul-Ameer Ahmed Al-Salman, et al.
Published: (2018-08-01) -
Amplification of HER-2 Gene in Benign and Malignant Breast Lesions in a Sample of Iraqi Women
by: Maysoon Abdul-Ameer Ahmed Al-Salman, et al.
Published: (2018-08-01)